Sfoglia per AUTORE
FERRERI A
Collezione AOU Novara

  

Items : 12

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
ASL Biella
AO Alessandria
AOU Città della Salute di Torino
AOU Novara

Zucca E; Vitolo U; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Ghiggi C; Pisani F; Zanni M; Liberati AM; Annibali O; Celli M; Bruna R; Orsucci L; Cabras MG; Tani M; Tucci A; Vanazzi A; Balzarotti M; Merli F; Stathis A; Gaidano G; Sassone M; Botto B; Conconi A; Chiappella A; Ferreri AJM; et alii...

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2024 Jan;35(1):118-129. doi: 10.1016/j.annonc.2023.10.095. Epub 2023 Nov 3.

2024
AO Alessandria
AOU Novara
AOU Città della Salute di Torino

Benedetti F; Luminari S; Vitolo U; Ferreri AJM; Latte G; Ciccone G; Bottelli C; Anastasia A; Boccomini C; Bossi E; Pennese E; Re F; Patti C; Pastore D; Cavallo F; Milone G; Ghiggi C; Pinto A; Corradini P; Tani M; Gaidano G; Zilioli VR; Pavone V; Arcari A; Puccini B; Volpetti S; Ferrero S; Tucci A; Botto B; et alii...

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. in Blood advances / Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Cortelazzo S; Galimberti S; Palumbo GA; Puccini B; Ferreri AJM; Ballerini F; Lucchini E; Arcaini L; Moita F; Zilioli V; Balzarotti M; Boccomini C; Stefoni V; Cavallo F; Re A; Di Rocco A; Tavarozzi R; Ghislieri M; De Luca G; Zaccaria GM; Alessandria B; Genuardi E; Pironti M; Grimaldi D; Arrigoni E; Ferrero S; Di Paolo A; Ladetto M;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AO Alessandria

Bertù L; Ladetto M; Pilerci S; Pinto A; Ramadan S; Marchesi F; Cavo M; Visco C; Romano A; Coviello E; Merli F; Passamonti F; Krampera M; Corradini P; Candoni A; Conconi A; Tosi P; Lanza F; Venditti A; Selleri C; Vallisa D; Visani G; Gambacorti-Passerini C; La Barbera EO; Rigacci L; Armiento D; Cilloni D; Corso A; Cardinali V; et alii...

Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):953-961. doi: 10.1002/hon.3074. Epub 2022 Sep 15.

2022
AO Alessandria
AOU Novara

Nassi L; Stepanishyna Y; Federico M; Inghirami G; Re A; Rigacci L; Carson KR; Ferreri AJM; Luminari S; De Souza CA; Nagler A; Montoto S; Horwitz SM; Cabrera ME; Pileri SA; Zing NPC; Manni M; Miranda E; Fischer T; Chiattone C; Civallero M;

Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study. in Advances in hematology / Adv Hematol. 2022 Jan 27;2022:5581772. doi: 10.1155/2022/5581772. eCollection 2022.

2022
AO Alessandria
AOU Novara

Martelli M; Barbiero V; Mengarelli A; Consoli U; Santoro A; Liberati AM; Ladetto M; Fraticelli V; Guarini A; Mannina D; Ferrando P; Corradini P; Musto P; Stelitano C; Ronci B; La Nasa G; Massimi S; Gaglione G; Cantore N; Inzoli A; Cardinale G; Cerqueti M; Turrini M; Arcaini L; Santini S; Ferreri AJM; Caparrotti G; Battistini R; Murineddu M; et alii...

MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Feb;8(2):e110-e121. doi: 10.1016/S2352-3026(20)30366-5.

2021
AOU Città della Salute di Torino
AOU Novara

Zambello R; Zucca E; Frezzato M; Osborne W; Liberati AM; Novak U; Cascavilla N; Davies A; Fox CP; Bernardi M; Gastaldi E; Cozens K; Fanni A; Singh V; Bromberg JEC; Re F; Patti C; Olivieri J; McKay P; Nassi L; Linton K; Botto B; Cellini C; Khwaja J; Cattaneo C; Re A; Cabras MG; Smith J; Ferreri AJM; et alii...

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL). in Frontiers in oncology / Front Oncol. 2021 Nov 5;11:730194. doi: 10.3389/fonc.2021.730194. eCollection 2021.

2021
AOU Città della Salute di Torino
AOU Novara

Balzarotti M; Rusconi C; Chiappella A; Cabras MG; Olivieri A; Gentile M; Annibali O; Loseto G; Tisi MC; Arcari A; Nassi L; Gini G; Di Rocco A; Ferreri AJM;

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.

2020
AOU Città della Salute di Torino
AOU Novara

Bertoni F; Ladetto M; Gaidano G; Cortelazzo S; Piccin A; Ferreri A; Grønbæk K; Molinari A; Santoro A; Jerkeman M; da Silva MG; Zamò A; Novero D; Paulli M; Barbero D; Kolstad A; Mahmoud AM; Schipani M; Ghione P; Favini C; Diop F; Stefoni V; Di Rocco A; Dahl C; Moia R; Kwee I; Evangelista A; Spina V; Eskelund CW; et alii...

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. in British journal of haematology / Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.

2014
ASL Biella
AOU Novara

Zucca E; Cavalli F; Gaidano G; Stathis A; Porro E; Kiesewetter B; Vitolo U; Martinelli G; Zinzani PL; Arcaini L; Magagnoli M; Ferreri AJ; Devizzi L; Conconi A; Raderer M; Franceschetti S;

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Jul;25(7):1404-1410. doi: 10.1093/annonc/mdu166. Epub 2014 May 5.

2014
AO Alessandria
AOU Novara

Pulsoni A; Baldini L; Mancuso S; Marino D; Bruno R; Rossi D; Spedini P; Rigacci L; Levis A; Musto P; Ladetto M; Merli F; d'Arco A; Stelitano C; Tucci M; Luminari S; Visco C; Cabras G; Spina M; Tucci A; Rusconi C; Varettoni M; Ambrosetti A; Chiappella A; Merli M; Bernuzzi P; Ferreri AJM; Ferretti VV; Rattotti S; et alii...

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Mar;22(3):689-695. doi: 10.1093/annonc/mdq416. Epub 2010 Sep 1.

2011
AOU Novara

Conconi A; Martinelli G; Lopez-Guillermo A; Zinzani PL; Ferreri AJM; Rigacci L; Devizzi L; Vitolo U; Luminari S; Cavalli F; Zucca E;